CME Presentations

Multiple Sclerosis


Presentations


Speakers


CME Information

Improving Multiple Sclerosis Care: Integrating Patient-Provider Perspectives


CMSC LogoPQH Logo

LEARNING OBJECTIVES

Session 1:

  • Incorporate accumulated clinical evidence, current guidelines, and emerging new clinical data into individualized selection of DMTs for MS as part of a comprehensive approach to management that includes SDM with patients, ongoing monitoring, and DMT optimization
  • Recognize the need to identify and address symptoms experienced by patients with MS, with attention to patients’ values and goals for treatment, and with appropriate selection of symptomatic interventions
  • Take a multidisciplinary approach to diagnosing and addressing psychological and cognitive issues in patients with MS, including identification of sources of psychosocial support and wellness interventions

Session 2:

  • Recognize the need to identify and address symptoms experienced by patients with MS, with attention to patients’ values and goals for treatment, and with appropriate selection of symptomatic interventions
  • Take a multidisciplinary approach to diagnosing and addressing psychological and cognitive issues in patients with MS, including identification of sources of psychosocial support and wellness interventions

ACKNOWLEDGEMENT

This activity is supported by educational grants from Biogen, Celgene, Genentech, and Sanofi Genzyme.

TUITION

Complimentary

GENERAL CME/CNE/CE INFORMATION

In order to successfully complete this continuing education activity, the participant must register for the activity, attend the activity, and complete the online Evaluation and Claim for Credit form.

DATE OF RELEASE / EXPIRATION

Live Activities
Current Management of Early to Relapsing Forms of Multiple Sclerosis: A Comprehensive Approach
June 20, 2019
10:00am – 11:00am ET

Living with Multiple Sclerosis: From Diagnosis to Initial Treatment and Relapse Management
July 25, 2019
11:00am-12:00pm ET

Enduring Material

The enduring material will be available from June 20, 2019 to July 25, 2020

Target Audience

Neurologists, primary care physicians, advanced practice clinicians, nursing professionals, physician assistants, pharmacists and other HCPs involved in the care of patients with MS.

Accreditation and Credit Information

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC), and Platform Q Health Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The CMSC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Certificate of Completion

A Certificate of Completion may be given upon completion of course requirements enabling you to register your credit with the appropriate licensing boards or associations. You may apply for other accreditations using the procedure established by the specific organization.

Disclosure of Unlabeled Use

CMSC and Platform Q Health Education require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees to participate in this activity. To participate in the activity, go to http://cmscscholar.com or www.NeuroSeriesLive.com. To receive credit, participants must (1) read the activity front matter, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

It is the policy of CMSC and Platform Q Health Education to ensure balance, independence, objectivity, and scientific rigor in all educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed any relevant financial relationships they or their spouse/life partner have within the previous 12 months with manufacturers of any commercial products/devices and/or providers of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. All presentations were reviewed by an independent clinician with no relevant financial relationships for the purpose of resolution of any identified conflict of interest and a determination of evidence-base and fair balance.

Faculty Disclosures

The faculty reported the following financial relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Scott D. Newsome, DO, MSCS, FAAN served as faculty for this activity. He has received consulting fees from Biogen, Genentech, Celgene, EMD Serono, Gerson Lehrman Group, and is a Clinical Adjudication Committee Member for a medDay Pharmaceuticals clinical trial. He is Principal Investigator for Biogen and Genentech clinical trials (paid directly to institution).
Kathleen Costello, MS, ANP-BC, MSCN served as faculty for this activity. She has disclosed no relevant financial relationships.
Julie Fiol, MSW, BSN, RN, MSCN served as faculty for this activity. She has disclosed no relevant financial relationships.
Ingrid Hanson served as faculty for this activity. She has disclosed no relevant financial relationships.
June Halper, MSN, APN-C, MSCN, FAAN served as planner and reviewer for this activity. She has disclosed no relevant financial relationships.
Laurie Scudder, DNP, NP served as nurse planner and reviewer for this activity. She has disclosed no relevant financial relationships.

All other CMSC and Platform Q Health Education staff who are in a position to influence content have disclosed no relevant financial relationships.

HARDWARE / SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Contact Information

If you have questions about this CME/CNE activity, please contact the CMSC at education@mscare.org or 201-487-1050.